
Опубликована: Апрель 10, 2025
Abstract The landscape of prenatal genetics continues to evolve rapidly, with improvements in processing speed and technology. Clinicians are tasked staying current the latest recommendations for genetic screening diagnosis order provide patient‐centered evidence‐based care. We present a review 15 societal guidelines that have been published or reaffirmed between 2016 2023 from American College Obstetricians Gynecologists (ACOG), Society Maternal Fetal Medicine (SMFM), Medical Genetics Genomics (ACMG), International Prenatal Diagnosis (ISPD). summary guidance carrier screening, cell‐free DNA (cfDNA) diagnostic testing, also discuss key principles. In brief, there several approaches range few select conditions (hemoglobinopathies, spinal muscular atrophy, cystic fibrosis) hundreds through expanded panels. Both ACOG ACMG support (ideally preconception) although differing about optimal approach number screen. With regards cfDNA ACOG, SMFM, ACMG, ISPD recommend offering all patients option screen common aneuploidies, consideration sex chromosome aneuploidies after counseling. While do not endorse microdeletion cfDNA, supports 22q11.2 deletion syndrome. societies unanimous recommending against evaluation rare autosomal trisomies. Finally, terms chromosomal microarray fetal structural anomalies, stillbirth, confirmation results. Next‐generation sequencing exome genome is recommended by ISPD, SMFM anomalies following normal karyotype and/or microarray. on other hand, does currently outside research setting. must robust literacy understand testing methodologies, benefits limitations options, engage equitable clinical practice.
Язык: Английский